CASI PHARMACEUTICALS INC's ticker is CASI and the CUSIP is 14757U109. A total of 70 filers reported holding CASI PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is - and the average weighting 0.4%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2022 | $91,000 | +40.0% | 112,777 | +39.6% | 0.01% | 0.0% |
Q4 2021 | $65,000 | +80.6% | 80,806 | +164.4% | 0.01% | +133.3% |
Q3 2021 | $36,000 | -77.4% | 30,560 | -53.8% | 0.00% | -72.7% |
Q1 2021 | $159,000 | +329.7% | 66,106 | +431.0% | 0.01% | +175.0% |
Q4 2020 | $37,000 | -37.3% | 12,450 | -67.7% | 0.00% | -60.0% |
Q3 2020 | $59,000 | +51.3% | 38,496 | +217.5% | 0.01% | +400.0% |
Q4 2017 | $39,000 | -45.8% | 12,124 | -70.3% | 0.00% | -50.0% |
Q3 2017 | $72,000 | – | 40,790 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Wellington Shields & Co., LLC | 896,137 | $4,185,000 | 2.27% |
Wellington Shields Capital Management, LLC | 888,333 | $4,149,000 | 0.67% |
Manatuck Hill Partners, LLC | 15,090 | $70,000 | 0.03% |
IHT Wealth Management, LLC | 10,725 | $50,000 | 0.01% |
Perceptive Advisors | 43,682 | $204,000 | 0.01% |
ALPS ADVISORS INC | 153,234 | $716,000 | 0.01% |
ROYCE & ASSOCIATES LP | 78,742 | $368,000 | 0.00% |
MEEDER ASSET MANAGEMENT INC | 5,863 | $28,000 | 0.00% |
Tower Research Capital LLC (TRC) | 5,974 | $28,000 | 0.00% |
METROPOLITAN LIFE INSURANCE CO/NY | 18,585 | $86,792 | 0.00% |